Citation:Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G 2012

From Cancer Guidelines Wiki

Citation


Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G. Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus. Gastroenterology 2012 Oct 3 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23041329.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Is surveillance cost-effective for follow-up of patients with BO?Dr Louisa Gordoncompleted
For which populations is screening for BO cost-effective?Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhilcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Is surveillance cost-effective for follow-up of patients with BO?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is surveillance cost-effective for follow-up of patients with BO?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For which populations is screening for BO cost-effective?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For which populations is screening for BO cost-effective?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. For which populations is screening for BO cost-effective?